# A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

> **NCT07015697** · PHASE1 · RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 76 (estimated)

## Conditions studied

- Recurrent or Metastatic Solid Tumors

## Interventions

- **DRUG:** Trastuzumab Deruxtecan

## Key facts

- **NCT ID:** NCT07015697
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-17
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07015697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07015697, "A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07015697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*